Treatment of refractory testis cancer: Salvage or savage chemotherapy?
- 31 July 1991
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (7), 932-936
- https://doi.org/10.1016/0277-5379(91)90150-c
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dose intensity and outcome with combination chemotherapy for germ cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Chemotherapy for Poor Risk Germ Cell Tumours An Independent Evaluation of the POM B/ACE RegimeBritish Journal of Urology, 1988
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1988
- Prognostic factors in metastatic testicular cancerInternational Journal of Andrology, 1987
- Multivariate analysis of prognostic variables in patients with disseminated non‐seminomatous testicular cancer: results from an EORTC multi‐institutional phase III studyInternational Journal of Andrology, 1987
- Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patientsCancer Treatment Reviews, 1983
- Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapyJournal of Surgical Oncology, 1983
- Etoposide and etoposide-ifosfamide therapy for refractory testicular tumorsCancer Treatment Reviews, 1982
- Non‐seminoma Germ Cell Tumours (Malignant Teratoma) of the Testis Results of Treatment and an Analysis of Prognostc Factors*British Journal of Urology, 1981